David M. DeMedio
Plus aucun poste en cours
Profil
Mr. David M.
DeMedio, CPA, is Chief Services Officer at USA Technologies, Inc.
Mr. DeMedio also served on the board at Gammacan International, Inc.
He received his undergraduate degree from the Shippensburg University of Pennsylvania.
Anciens postes connus de David M. DeMedio
| Sociétés | Poste | Fin |
|---|---|---|
| CANTALOUPE, INC. | Directeur Financier/CFO | 31/08/2015 |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Directeur/Membre du Conseil | 17/09/2008 |
Formation de David M. DeMedio
| Shippensburg University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CANTALOUPE, INC. | Finance |
| Entreprise privées | 1 |
|---|---|
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
